Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal papillary necrosis.

Amy E Brix1

  • 1Experimental Pathology Laboratories, Inc, Research Triangle Park, North Carolina 27709, USA. brix@niehs.nih.gov

Toxicologic Pathology
|January 7, 2003
PubMed
Summary
This summary is machine-generated.

Renal papillary necrosis (RPN) is a serious kidney condition linked to various medications. Understanding its causes and animal models is crucial for human health, despite study limitations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatic Transcriptomic Patterns in the Neonatal Rat After Pentabromodiphenyl Ether Exposure.

Toxicologic pathology·2019
Same author

National Toxicology Program Position Statement on Informed ("Nonblinded") Analysis in Toxicologic Pathology Evaluation.

Toxicologic pathology·2019
Same author

Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.

Toxicologic pathology·2014
Same author

Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.

Toxicologic pathology·2010
Same author

Thyroid follicular lesions induced by oral treatment for 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds in female Harlan Sprague-Dawley rats.

Toxicologic pathology·2010
Same author

Reproductive lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin and dioxin-like compounds.

Toxicologic pathology·2009
Same journal

Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

Toxicologic pathology·2026
Same journal

Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

Toxicologic pathology·2026
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
See all related articles

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Renal papillary necrosis (RPN) is a significant clinical issue, particularly in England and Australia.
  • RPN affects 15% to 20% of patients requiring renal transplants in these regions.
  • Numerous nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics are implicated in human RPN cases.

Purpose of the Study:

  • To review the current understanding of renal papillary necrosis (RPN).
  • To discuss the potential mechanisms and contributing factors of RPN.
  • To evaluate the limitations of using animal models for studying human RPN.

Main Methods:

  • Literature review of existing studies on RPN.
  • Analysis of epidemiological data linking drug use to RPN.

Related Experiment Videos

  • Examination of proposed pathogenetic mechanisms of RPN.
  • Assessment of anatomical and technical challenges in animal RPN models.

    • Main Results:

    • Several common medications, including NSAIDs like aspirin and ibuprofen, are associated with RPN.
    • While the precise mechanism remains unclear, several theories are supported by scientific evidence.
    • Significant anatomical and technical hurdles limit the utility of animal models in RPN research.

    Conclusions:

    • RPN is a serious adverse drug reaction with substantial clinical impact.
    • Further research is needed to elucidate RPN mechanisms and improve animal models.
    • Understanding these factors is vital for preventing and treating RPN in humans.